JCR Pharmaceuticals (JCRRF) News Today $4.57 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period JCR Pharmaceuticals Initiates Phase III Clinical Trial of JR-142 in Japan, a Long-Acting Growth Hormone TherapyDecember 20 at 12:05 PM | businesswire.comJCR Pharmaceuticals Launches Key JR-142 Clinical TrialDecember 19 at 2:26 AM | tipranks.comJCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest UpdateDecember 17, 2024 | americanbankingnews.comMEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Announce Initiation of First Dosing in Phase I/II Clinical Trial of JR-446 for Mucopolysaccharidosis Type IIIB in JapanDecember 5, 2024 | businesswire.comJCR Pharmaceuticals Initiates Clinical Trial for MPS IIIBDecember 3, 2024 | tipranks.comJCR Pharmaceuticals Faces Financial Decline Amid Strategic ChangesNovember 18, 2024 | tipranks.comJCR Pharmaceuticals Completes Share Buyback for Strategic GrowthNovember 1, 2024 | markets.businessinsider.comJCR Pharmaceuticals Initiates First Dosing in Phase I Clinical Trial of JR-441 for Mucopolysaccharidosis Type IIIAOctober 31, 2024 | businesswire.comJCR Pharmaceuticals Presents Preclinical Gene Therapy Research at the European Society of Gene and Cell Therapy 31st Annual CongressOctober 23, 2024 | businesswire.comJCR Pharmaceuticals Advances Gene Therapy ResearchOctober 23, 2024 | markets.businessinsider.comMesoblast: Undervalued Due To Remestemcel-L's Substantial Growth PotentialSeptember 30, 2024 | seekingalpha.comJCR Pharmaceuticals Highlights Innovative Gene Therapy Research at the 7th International Forum of Lysosomal DisordersJuly 19, 2024 | businesswire.comModalis Therapeutics Corporation (4883.T)May 25, 2024 | finance.yahoo.comJCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with AlexionMarch 19, 2024 | finance.yahoo.comJCR Pharmaceuticals Co Ltd 4552March 2, 2024 | morningstar.comJCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease CommunityFebruary 29, 2024 | finance.yahoo.comJCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage DisordersFebruary 14, 2024 | finance.yahoo.comJCR Pharmaceuticals earnings preview: what Wall Street is expectingJanuary 25, 2024 | markets.businessinsider.comJCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024January 25, 2024 | finance.yahoo.comJCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® TechnologyDecember 21, 2023 | finance.yahoo.comJCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy CollaborationDecember 21, 2023 | finance.yahoo.comU.S. FDA Grants Orphan Drug Designation to JR-441 for the Treatment of Mucopolysaccharidosis Type IIIA (MPS IIIA)December 15, 2023 | finance.yahoo.comJCR Pharmaceuticals doses first patient in MPS IIIA trialNovember 13, 2023 | msn.comJCR Pharmaceuticals earnings preview: what to expectOctober 24, 2023 | markets.businessinsider.comJCR Pharmaceuticals Announces 52-Week Interim Data from its Global Phase I/II Study of JR-171 in Individuals with Mucopolysaccharidosis Type I (MPS I)September 29, 2023 | finance.yahoo.comJCR Pharmaceuticals Shares Jump After It Raises Earnings GuidanceSeptember 28, 2023 | marketwatch.comHere's what Wall Street expects from JCR Pharmaceuticals's earnings reportJuly 27, 2023 | markets.businessinsider.comJCR Pharmaceuticals Co Ltd (4552)May 17, 2023 | investing.comItaly's Angelini invests up to $506 million in Japan's JCR for epilepsy drugMay 11, 2023 | news.yahoo.comItaly's Angelini invests up to $506 mln in Japan's JCR for epilepsy drugMay 11, 2023 | reuters.comJCR Pharmaceuticals Announces Research Collaboration, Option and License Agreement with Alexion to Develop a Therapy Using J-Brain CargoⓇ for Neurodegenerative DiseaseApril 3, 2023 | finance.yahoo.com Get JCR Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JCRRF and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… JCRRF Media Mentions By Week JCRRF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JCRRF News Sentiment▼0.330.60▲Average Medical News Sentiment JCRRF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JCRRF Articles This Week▼30▲JCRRF Articles Average Week Get JCR Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JCRRF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AZNCF News DSNKY News KYKOF News MAYNF News OPHLY News OTSKF News RHHVF News SNYNF News SCLXW News VRBCF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:JCRRF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding JCR Pharmaceuticals Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share JCR Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JCRRF Stock Alerts